Welcome to our dedicated page for CELESTICA SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica Inc. filings document operating results, governance actions, capital-structure matters, and shareholder communications for a Canadian issuer with common shares registered under CLS on the New York Stock Exchange.
Recent disclosures include Form 8-K reports for quarterly and annual financial results, Regulation FD communications, board and committee transitions, annual meeting records, material-event reporting, and share repurchase authorization. The definitive proxy statement covers director elections, executive compensation, shareholder voting procedures, governance policies, and related proxy matters for Celestica’s public-company oversight.
Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director Kulvinder Ahuja received an equity grant. On August 11, 2026, Ahuja was granted 133 Director Restricted Share Units (D‑RSUs), each representing a contingent right to receive one common share or an equivalent cash value at the issuer’s election. These D‑RSUs vest on May 20, 2027, and Ahuja now holds 700 D‑RSUs in total on a direct basis.
Celestica Inc. entered into an Underwriting Agreement on August 5, 2026 to sell 9,677,419 common shares at an offering price of $310.00 per share. The company also granted the underwriters a 30‑day option to purchase up to 1,451,612 additional shares at the same price, which was fully exercised on August 6, 2026.
The offering, conducted under an effective Form S-3 registration statement and an August 5, 2026 prospectus supplement, is expected to generate approximately $3.39 billion in net proceeds after underwriting discounts, commissions and expenses. Celestica plans to use the net proceeds for working capital, to support investments in capital expenditures, and for other general corporate purposes. The agreement includes customary representations, warranties, conditions to closing, indemnification provisions and termination rights, and a Canadian legal opinion on the validity of the securities from Blake, Cassels & Graydon LLP.
CELESTICA INC Chief Executive Officer Robert Mionis reported indirect sales of 51,061 Common Shares on August 5, 2026 through Mionis 2026 GRAT Number Two, at weighted average prices between $361.89 and $378.50 per share under a Rule 10b5-1 plan adopted March 11, 2026. Following these trades, he reports holdings of 453,697 Common Shares directly and 210,445 indirectly via Mionis 2026 GRAT Number One.
Celestica Inc. Chief Executive Officer Robert Mionis reported indirect sales of 98,453 common shares by Mionis 2026 GRAT entities on August 4, 2026. The non-derivative sales were executed in multiple open-market transactions at weighted-average prices, with individual trade prices within disclosed ranges from $360.00 to $374.43 per share, pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026.
After these transactions, reported holdings comprised 453,697 common shares held directly and 210,445 shares held indirectly through Mionis 2026 GRAT Number One.
Celestica Inc chief financial officer Mandeep Chawla sold 16,117 common shares on August 4, 2026 in 15 open market or private transactions at weighted average prices between $360.18 and $374.16 per share, under a Rule 10b5-1 trading plan adopted on March 13, 2026. Prices reported are weighted averages for trades executed within specified intraday ranges.
Celestica Inc. is conducting a primary offering of 9,677,419 Common Shares at $310.00 per share, for gross proceeds of $2,999,999,890. Underwriters receive $5.115 per share in discounts, resulting in proceeds to Celestica of $304.885 per share, or $2,950,499,892 before approximately $1.8 million of offering expenses. The company has granted underwriters a 30‑day option to purchase up to 1,451,612 additional shares.
Net proceeds are estimated at about $2.95 billion (or $3.39 billion if the option is fully exercised), to be used for working capital, capital expenditures and other general corporate purposes. After the offering, Celestica expects to have 124,659,505 shares outstanding, or 126,111,117 if the option is fully exercised. LTM revenue to June 30, 2026 was $15.6 billion with GAAP operating margin of 8.8% and non‑GAAP adjusted operating margin of 7.9%.
Celestica Inc. is conducting a primary offering of up to $3,000,000,000 of its common shares under an effective shelf registration. The company expects to receive net proceeds, after underwriting discounts and expenses, to fund working capital, capital expenditures and other general corporate purposes.
Celestica, an Ontario‑based technology company listed on the NYSE and TSX under “CLS,” operates through two segments: Connectivity and Cloud Solutions (CCS) and Advanced Technology Solutions (ATS). For the last twelve months (LTM) ended June 30, 2026, revenue was $15.6 billion, up approximately 47% from the prior LTM period, with CCS contributing $12.3 billion and ATS $3.3 billion. GAAP operating margin was 8.8% and non‑GAAP adjusted operating margin 7.9%.
LTM GAAP diluted EPS were $9.62 and non‑GAAP adjusted diluted EPS $8.16. Cash provided by operations was $1.144 billion and non‑GAAP free cash flow $529.8 million. GAAP ROIC was approximately 51.5% and non‑GAAP adjusted ROIC approximately 46.5%. As of August 4, 2026, 114,982,086 common shares were outstanding; this is a baseline figure, not the amount being offered. Recent initiatives include collaborations with AMD on a 1.6T scale‑up switch for its Helios AI platform and a 1.6T co‑packaged optics program with a hyperscale customer.
Celestica Inc reported that Chief Executive Officer Robert Mionis, acting indirectly through Mionis 2026 GRAT Number Three, sold 9,543 common shares on July 31, 2026 in a series of open-market transactions at weighted average prices between $360.47 and $374.49 per share, executed under a Rule 10b5-1 trading plan adopted on March 11, 2026. Following these trades, reported holdings included 453,697 common shares held directly, plus 210,445 shares via Mionis 2026 GRAT Number One and 145,565 shares via Mionis 2026 GRAT Number Two.
Celestica Inc Chief Financial Officer Mandeep Chawla reported selling 883 Common Shares of Celestica on July 31, 2026, in nine non-derivative transactions reported as sales in open market or private transactions. Per‑share prices ranged from $360.0000 to $374.0300. All sales were effected under a Rule 10b5-1 trading plan adopted on March 13, 2026, with several trades reported using weighted average prices over specified intra-day ranges.